HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A vaccine for hypertension based on peptide AngI-R: a pilot study.

AbstractAIMS:
We aim to modulate the renin-angiotensin system (RAS) by active immunization against angiotensin I/II, potentially by a novel type of peptide--'AngI-R' for the treatment of hypertension.
METHOD:
27 spontaneous hypertensive rats (SHRs) were randomly divided into 3 groups (n=9). Effect of AngI-R on systolic blood pressure of SHRs was determined by its subcutaneous injection into SHRs with anti-angiotensin peptide AngI-R, captopril, physiological salt solution in the same schedule. Systolic blood pressure was monitored by tail-cuff arterial blood pressure measurement method and then calculated from the average of three measurements in each animal at a desired time (0, 4, 8, 16W). AngI, AngII and anti-AngI antibody were detected by ELISA and western blotting method. At the end, the pathologic changes in different organs of SHRs were observed.
RESULT:
The results exhibited a marked effect to lower the systolic blood pressure (-15 mmHg) of SHRs after subcutaneous injection with peptide AngI-R. The anti-hypertensive effect lasted for over 1 month. The level of AngI and AngII in the vaccinated group, after administration of AngI-R was lower than the one in the control group and the pre-administered group. The anti-AngI/II antibody titre in the experiment group significantly increased.
CONCLUSION:
The peptide AngI-R was able to decrease the blood pressure of SHRs. The peptide AngI-R induced an immune response to inhibit AngI and AngII, resulting in the decrease in blood pressure in SHRs.
AuthorsFang Hong, Wu Yong Quan, Rabindra Pandey, Shen Yi, Liu Chi, Li Zhan Xia, Ma Yuan, Lou Ming
JournalInternational journal of cardiology (Int J Cardiol) Vol. 148 Issue 1 Pg. 76-84 (Apr 01 2011) ISSN: 1874-1754 [Electronic] Netherlands
PMID19932924 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2009 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Isoantibodies
  • Vaccines, Subunit
  • Angiotensin II
  • Angiotensin I
Topics
  • Angiotensin I (administration & dosage, antagonists & inhibitors, therapeutic use)
  • Angiotensin II (administration & dosage, antagonists & inhibitors, therapeutic use)
  • Animals
  • Blood Pressure (drug effects, physiology)
  • Hypertension (pathology, prevention & control)
  • Isoantibodies (biosynthesis)
  • Male
  • Pilot Projects
  • Rabbits
  • Random Allocation
  • Rats
  • Rats, Inbred SHR
  • Vaccines, Subunit (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: